Biotechnology Companies in United States (US)
Location
Category
List of Biotechnology companies in United States (US)
633 companies
Sort by
At Gabe, Inc., we understand that each business is unique, and a one-size-fits-all approach simply won’t work.
Our experienced team boasts a proven track record of success, ensuring that we consistently exceed client expectations. We take a unique approach, developing long-term strategies that align with both company and client goals.
We are more than just a service provider—we are your trusted partner in navigating complex projects and achieving your objectives.
We provide comprehensive clinical trial services to pharmaceutical companies and research institutions, offering a wide range of studies focused on innovative treatments for memory loss, depression, and other neurological and psychiatric conditions.
Established in 1978, Irvine Clinical Research has a long history of contributing to medical advancements, with a dedicated team of experienced physicians and researchers committed to delivering high-quality care and advancing scientific knowledge. Our commitment to patient safety and rigorous research practices has made us a trusted partner in the pharmaceutical industry.
With five research centers across California, including locations in Irvine, Long Beach, Inglewood, and Riverside, we are uniquely positioned to support a diverse range of clinical trials.
We strive to provide our participants and sponsors with the highest quality of care, service, and commitment.
Avioq provides flexible contract development and manufacturing services, catering to a wide range of needs from exploratory research and proof-of-concept projects to feasibility studies and large-scale production.
We are committed to partnering with clients to navigate the complex regulatory landscape, ensuring your products achieve FDA and CE Mark approval efficiently and effectively. Our focus on rapid delivery and adherence to the highest quality standards makes us a trusted CDMO partner for companies seeking to bring innovative diagnostic solutions to market.
We support researchers across Duke University and beyond by providing cutting-edge genomic technologies and fostering interdisciplinary collaboration. Our team combines expertise in data science, bioinformatics, and traditional laboratory techniques to tackle complex biological questions.
GCB offers a unique blend of core facilities, educational programs, and collaborative research opportunities, empowering scientists to advance their work in areas such as **big data** analysis, **genomics** research, and the development of novel genomic tools. We are dedicated to training the next generation of researchers in these vital fields.
We partner with select companies to develop compelling grant proposals, leveraging our team of scientists and entrepreneurs to craft winning narratives.
Grant Engine distinguishes itself through a proven track record of exceeding the national average win rate – achieving 2x to 4x higher success – driven by our proprietary Find, Win, and Manage services, including a Streamline AI platform and expert review processes. We’re dedicated to helping innovative companies access significant funding opportunities from agencies like the NIH, SBIR, and beyond.
With over a decade of experience, Grant Engine has secured over $150 billion in funding for clients across diverse sectors, including biotechnology, defense, and space technologies.
Our mission is to enhance patient outcomes by delivering optimal platelet potency – consistently achieving 7-9x higher concentrations than competing kits, all at a significantly reduced cost.
Ycellbio’s patented technology, combined with direct-to-provider pricing and a commitment to customer feedback, has established us as the world’s most widely adopted PRP/PRF device, trusted by medical professionals in over 40 countries. We are dedicated to advancing regenerative medicine through accessible and reliable solutions.
From our state-of-the-art manufacturing facility to our comprehensive clinical support, Ycellbio Medical is committed to excellence and innovation.
Since 1994, Zymo Research has been dedicated to simplifying complex scientific workflows. Our core expertise lies in nucleic acid purification technologies, exemplified by our DNA Purification Made Simple™ and RNA Purification Made Simple™ platforms, which are pushing the boundaries of what’s possible in molecular analysis.
What distinguishes Zymo Research is our commitment to user-friendly solutions and reliable performance. We offer a comprehensive portfolio encompassing sample collection & preservation, DNA/RNA purification, NGS library preparation, and microbiome analysis – all underpinned by rigorous quality control and a dedication to supporting the scientific community. We are committed to quality and guarantee that all of our products and service will meet and exceed your expectations. We pledge to be honest and responsible for everything we do with you. We will treat you as we would like to be treated. Together, we will build a brighter future.
We are developing and manufacturing acellular human tissues – essentially, bioengineered ‘spare parts’ – that are designed to be universally implantable and regenerate with the patient’s own cells. Our core technology, the Acellular Tissue Engineered Vessel (ATEV™), is a first-in-class, bioengineered human vessel for extremity arterial trauma, recently receiving full FDA approval.
Humacyte’s approach leverages a proprietary bioengineering platform to transform human cells into regenerative biologic tissues, offering a potential solution for a wide range of injuries, diseases, and chronic conditions, including vascular trauma, tracheal replacement, and dialysis access. We are committed to bringing first-in-class regenerative medicine products to market, ultimately saving and improving patient lives.
Founded in 2004, Humacyte has rapidly advanced its technology and secured key regulatory milestones, including RMAT expedited review and priority designation for extremity arterial repair. Our team of dedicated scientists and engineers is focused on expanding our pipeline and realizing the full potential of our platform.
As a wholly owned, integrated organization of over 146 employees across 30+ clinical sites nationwide, M3 Wake Research partners with biopharmaceutical, biotechnology, and CROs to deliver superior clinical trial experiences.
We pride ourselves on our uncompromising approach to quality, integrity, and expeditious data delivery, consistently exceeding sponsor expectations. Our team of board-certified physicians has successfully completed over 7,000 clinical trials, demonstrating our commitment to advancing medical knowledge and improving patient care.Clinical Trial Network, Phase I-IV Trials, Clinical Research
With 30+ years of experience and 2,000+ clinical studies conducted, we provide comprehensive support for Phase I-IV trials, leveraging a team of experienced PIs and a commitment to investigator diversity.
Elite Clinical Network distinguishes itself through its hands-on management approach, ensuring meticulous attention to detail and unparalleled quality in every study. We are dedicated to accelerating medical advancements while maintaining the highest standards of compliance. Vaccine research and Phase 1 Research are key areas of expertise.
We provide a vital platform for professional development, networking, and knowledge sharing, offering technical training sessions, facility tours, and career development opportunities. Our events are specifically designed to support Young Professionals and students entering the life sciences field.
As a chapter of the International Society of Pharmaceutical Engineers (ISPE), we foster collaboration and innovation within the biotech, pharma, and medical device industries. We are committed to advancing best practices and supporting the growth of the life sciences sector in the Greater Los Angeles Area. Founded in 1995, we have grown to a team of 201-500 professionals, headquartered in Irvine, California.
We empower researchers and breeders across diverse sectors—crops, fruits, vegetables, forestry, flowers, livestock, aquaculture, poultry, and companion animals—with cutting-edge tools to accelerate and optimize breeding programs. Our proprietary Genotyping by Targeted Sequencing (GBTS) technology delivers unparalleled precision, scalability, and efficiency, driving transformative breakthroughs in agriculture and animal science.
With a global presence spanning the Americas, EMEA, and Asia, MolBreeding partners with researchers and industry leaders worldwide to enhance agricultural productivity and promote sustainability. We have developed over 500 marker panels across more than 100 species and have genotyped over 2 million samples.
MolBreeding Biotechnology A Global Next Generation Sequencing and Genotyping Service Provider
Ameritox provides comprehensive drug testing solutions, including urine drug testing and hair follicle testing, to a wide range of clients. Our services are designed to meet the evolving needs of the healthcare industry, helping providers stay compliant with regulations and protect patients from misuse and abuse.
We are committed to innovation and accuracy, continually investing in technology and expertise to deliver the highest quality drug testing services. Ameritox is an equal opportunity employer, dedicated to providing reliable and trustworthy data for a safer healthcare landscape.
We support women’s careers, leadership, and entrepreneurship across the biotechnology, pharmaceutical, and medical technology sectors. Our chapter leverages the region’s dynamic ecosystem, benefiting from its concentration of world-class institutions like Duke University, the University of North Carolina at Chapel Hill, and North Carolina State University, alongside a robust venture capital community and major industry players.
WIB-RTP provides a range of resources including professional development programming, mentorship through our MAPS program, leadership advancement opportunities, and networking events. We are committed to opening doors and building a connected, supportive network where women can thrive at every stage of their careers.
Founded in 2010, we’ve grown to serve Raleigh, Durham, and Chapel Hill, and continue to expand our impact within the broader life sciences landscape.
We provide a single point of contact for pharmaceutical partners seeking to commercialize rare and specialized therapies, leveraging our extensive network of 64 million potential patients.
Our expertise lies in navigating complex global healthcare systems, offering tailored solutions from Named Patient Programs to full commercialization, supported by a team of experienced professionals.
WODA’s value to pharmaceutical & biotech companies with rare disease and specialty portfolio includes single point of contact for 158 countries, access to 210 million potential rare disease patients, and a full-service solution with deep understanding of local healthcare systems. We are committed to improving patient access to life-saving treatments.
We provide critical resources and expert consulting services to organizations navigating the complexities of global health agreements and vaccine manufacturing. Our work centers on translating policy into tangible impact, ensuring that vital medical innovations reach underserved populations worldwide.
GHIAA’s core offering, the MAPGuide Ⓡ Platform, empowers practitioners and policymakers to analyze key contractual provisions within global health agreements, fostering transparency and driving equitable access. We also offer strategic insights and consulting services to support access plans and policies, leveraging our extensive experience in negotiating these crucial agreements.
We are dedicated to providing clinicians with advanced, biomarker-driven tests – like our lead platform, Oncuria® – for the early detection, monitoring, and prediction of bladder cancer recurrence.
Built on a decade of research and supported by $20 million in non-dilutive funding, Oncuria® is a multiplex urine-based liquid biopsy that measures 10 validated protein biomarkers.
By combining rigorous science, clinical validation, and scalable infrastructure, Nonagen Bioscience is bringing precision diagnostics into everyday urologic practice, enabling clinicians to reduce unnecessary procedures and improve patient outcomes.
We serve laboratories across the United States and beyond, offering comprehensive support including on-site service, depot repair, and preventative maintenance.
Nova Biotech distinguishes itself through over 30 years of experience, NIST traceable standards, and a commitment to providing best-in-class service and support to our clients. We also offer new and refurbished instrument sales, representing Gilford, Kontron, and Unico.
Our team of experienced technicians is dedicated to ensuring the optimal performance of your instrumentation, minimizing downtime and maximizing your research productivity.
We accelerate the development of life-saving therapies by creating human tissue-on-a-chip models that accurately mimic the human body’s vascular system. These microphysiological systems, including VMO™, VMT™, and VMB™ models, provide a more physiologically relevant environment for testing drug compounds and predicting efficacy and safety – ultimately reducing the risk of clinical trial failures.
Aracari’s technology is transforming the way drugs are developed, offering a significant advantage over traditional methods. Our solutions are particularly impactful in oncology, immuno-oncology, and blood-brain barrier research, helping to bring treatments to patients faster.
We provide a comprehensive range of advanced technologies, including microfluidic systems, diamond interaction chambers, and liposome extruders, catering to the pharmaceutical, biotech, cosmetic, and food industries.
Genizer’s commitment lies in delivering innovative equipment and services that enable our clients to develop and manufacture cutting-edge nano materials and formulations – from liposomes and emulsions to nanoparticles and gene delivery systems. We support research and development across a diverse spectrum of applications, including cell disruption and cosmetics.
Founded in 2009, Genizer has established itself as a trusted partner for organizations seeking to push the boundaries of nanotechnology.
We help emerging Life Science companies maximize savings, time, and regulatory compliance across key areas including Procurement, Financial Services, Consulting, and Investor Relations.
BioMAS leverages deep industry connections and extensive procurement experience to deliver exceptional value, from short-term project assistance to complete outsourcing. Our team combines decades of experience in laboratory operations, financial analysis, and regulatory compliance, ensuring our clients achieve their objectives efficiently and effectively.
BioMAS has a proven track record of success, as demonstrated by our case study with Natera, where we secured a 24% savings on a $1.7 million pipette tips order. We are committed to providing innovative and reliable solutions to support the growth of Life Science organizations.
We provide comprehensive biotech solutions, including plant genetic sequencing, DNA analysis, and RNA analysis, to help our clients accelerate research and development.
GTR leverages cutting-edge computational biology and bioinformatics techniques to deliver actionable insights and drive innovation. Our team combines deep scientific expertise with a practical, results-oriented approach, supporting clients from initial research through commercialization.
Founded in 2017, GTR has quickly established itself as a trusted partner for companies seeking to unlock the full potential of plant-based organisms. We are committed to advancing scientific discovery and supporting the growth of these dynamic sectors.
We provide comprehensive analytical testing services to businesses operating within the hemp, CBD, and lavender industries. Our specialized testing capabilities include cannabinoid analysis, terpene analysis, heavy metal detection, pesticide residue testing, fatty acid profiling, and total lipid analysis – ensuring product safety and regulatory compliance.
Kennebec Analytical Services offers tailored consulting services for growers, CBD product development, and business-initiated contract research, supporting clients every step of the way. We are committed to delivering accurate, reliable results and personalized support to meet the unique needs of our clients.
Founded in 2020, we’ve quickly established ourselves as a trusted partner for businesses seeking rigorous testing and expert guidance in the rapidly evolving cannabis and lavender sectors. Our team of experienced scientists and consultants is dedicated to upholding the highest standards of quality and precision.
We specialize in developing and deploying the SpectraWave system, a patented technology that delivers rapid, accurate, and actionable insights from biological samples.
Claro Scientific’s core expertise lies in optics and photonics, enabling us to offer solutions for medical diagnostics, process analysis, and protein characterization. Our reagentless, portable system provides significant improvements in quality, outcomes, and cost savings across a range of applications, from clinical laboratories to field research.
Founded in 2006, Claro Scientific is dedicated to transforming healthcare and scientific discovery through innovative optical technology.
At Creative Scientist, we bridge the gap between discovery and development by generating reproducible, high-quality data using advanced cell and tissue models.
Our approach, Investigative Cell Biology, combines scientific rigor with flexibility, allowing us to tackle complex translational challenges. We offer a range of services, including multi-well organoid assays, microvascular networks, and barrier tissue platforms, all designed to accelerate your R&D timelines and deliver reliable results.
Founded in 2010, Creative Scientist has grown to a team of 5, dedicated to providing exceptional service and expertise to our clients. We are committed to reducing drug development costs and improving toxicological risk assessment, ultimately contributing to safer and more effective therapies.
We support life science researchers by providing expertise and unique RepliGut® Systems, a collection of in vitro models derived from stem cells, designed to accurately replicate human intestinal physiology.
Altis Biosystems’ RepliGut® models overcome the limitations of conventional cell lines and animal models, offering a highly accurate and scalable platform for studying drug disposition, toxicity, and efficacy – ultimately reducing the reliance on animal testing and accelerating the drug development process. Our RepliGut® Planar models, in particular, advance novel pharmaceuticals by harnessing the potential of human donor intestinal stem cells.
We offer a range of services including InflammaScreen, StemTox, and custom assays, alongside our core RepliGut® Kits, enabling researchers to gain valuable insights into human gut biology. Altis Biosystems is committed to advancing New Approach Methodologies (NAMs) for a safer and more effective future in drug development.
We are revolutionizing early-life nutrition by developing a science-led, women-owned solution that leverages our patented technology to create a more sustainable and accessible alternative to traditional infant formula.
BIOMILQ’s approach addresses the critical need for more of the benefits of breast milk in infants, particularly those who cannot breastfeed. Our technology offers a scalable and ethical pathway to bridging the gap between breast milk and infant nutrition, contributing to improved infant health outcomes and supporting families worldwide.
Founded in 2019, BIOMILQ is rapidly advancing its research and development, with a team of dedicated scientists and a commitment to social impact. We are focused on expanding the applications of our technology to address broader nutritional needs and improve maternal and infant health globally.
We serve healthcare providers, genetic counselors, and researchers seeking to accelerate and improve the accuracy of genetic testing. Our mission is to transform rare disease diagnostics and expand access to precision medicine through innovative technology.
Virtual Geneticist®, our proprietary AI platform, streamlines genomic data interpretation, prioritizing potential disease-causing variants with ACMG classifications and literature associations. We’ve been recognized for our innovation, including winning the 2024 Innovation Award for AI-Driven Rare Disease Diagnosis and Early Cancer Detection.
Breakthrough Genomics is dedicated to advancing the field of genomics and improving patient outcomes through cutting-edge technology and collaborative partnerships.
Alzheimer’s disease, the most common form of dementia, impacts over 6 million Americans and is projected to affect 153 million people worldwide by 2050. Early and accurate detection is paramount for effective intervention and improved patient outcomes.
Our flagship product, AugMem™, is an FDA-classified cognitive assessment aid designed for healthcare professionals, clinical researchers, and academics. Augnition Labs combines cutting-edge AI with the scientific expertise of our co-founders, Dr. Michael Yassa and Dr. Adele Gilpin, to deliver transformative solutions in the field of cognitive health.
Our Rapid Evolution Platform™ leverages a nature-based approach combined with cutting-edge AI to identify and unlock useful traits in plants faster and more affordably than traditional methods. We’re tackling the challenges of modern agriculture – including water scarcity, fertilizer overuse, and climate change – by harnessing the power of diverse genetic resources and predictive modeling.
Unlike conventional breeding, our technology dramatically reduces the time and resources needed to develop superior crop varieties. We’re focused on improving crop efficiency, nutritional value, and climate resilience, ultimately creating a more stable and impactful agricultural industry. We are committed to improving the world through innovative plant breeding.
We accelerate drug discovery and development by providing functional, multi-organ in vitro platforms that recreate key components of organs in an interconnected, functional system.
Hesperos’ Human-on-a-Chip technology offers unprecedented preclinical insight into disease states and the human response to therapeutics, reducing the need for animal testing and enabling research into rare diseases. Our patented platform allows for simultaneous assessment of ADME, disease modeling, and drug-drug interactions, providing a comprehensive understanding of drug safety and efficacy.
Founded in 2015, Hesperos is a leader in this innovative field, collaborating with research institutes and commercial partners to bring hope to patients worldwide.
Founded by Robert S. Langer, one of the most cited engineers in history and a recipient of the United States National Medal of Science, VitaKey leverages pharmaceutical-level rigor and science to address global nutrition challenges.
Our platform, developed at the Langer Lab at MIT, utilizes advanced encapsulation technology to deliver essential nutrients, probiotics, vitamins, and flavors with targeted and time-controlled release, offering a sustainable solution for improved health and wellness. We are supported by a team of nutrition science experts, including Dr. Ana Jaklenec, and guided by the vision of Catherine B. Reynolds, a renowned philanthropist and innovator.
VitaKey’s technology has applications across the food chain, from infant formula to animal feed, and is poised to revolutionize how we approach nutrition and address issues of food insecurity and malnutrition.
We focus on providing innovative chemical solutions to pharmaceutical and biotechnology companies, accelerating drug development timelines and addressing critical unmet therapeutic needs. Our team of experienced chemists and researchers leverages cutting-edge technology and deep scientific expertise to deliver high-quality compounds and support complex research projects.
Boragen’s services are particularly valuable for organizations engaged in early-stage drug discovery, medicinal chemistry, and lead optimization. We are dedicated to unlocking novel medicine to serve patients and contribute to advancements in healthcare. We operate from our headquarters in Durham, North Carolina, and maintain a presence in San Francisco, California.
We provide custom synthesis, kilo-scale manufacturing, and bioconjugation services, supporting early-stage pharmaceutical development programs worldwide. Our expertise lies in creating innovative solutions for targeted radionuclide delivery, accelerating the advancement of diagnostic and therapeutic medicine.
Macrocyclics leverages a cutting-edge research and development strategy, combined with a commitment to rigorous quality control, to meet the evolving needs of the medical community. We collaborate with academic and commercial partners to drive innovation in molecular imaging and personalized medicine.
With over 25 years of experience, Macrocyclics has established itself as a trusted partner in the radiopharmaceutical space, dedicated to improving patient outcomes through advanced chemical technologies.
We provide research services and products to a global clientele, including NIH, pharmaceutical and biotechnology companies, and universities. Our core mission is to simplify proteomic biomarker discovery and enable serological and immune profiling of whole proteomes, significantly reducing the time and cost associated with traditional methods.
ADI’s flexible and robust microarray platform facilitates the discovery of diagnostic biomarkers, vaccine candidates, and therapeutic antibody discovery. Founded in 2004, we pride ourselves on our diverse team of scientists and our commitment to innovation and collaboration, serving the research community worldwide.
Our leadership team brings extensive experience from leading biotechnology and pharmaceutical companies, ensuring a strong foundation for continued growth and success.
We focus on addressing the underlying mechanisms of lung disease, particularly the dehydration associated with conditions like CF, by utilizing novel peptides that reduce airway surface density of epithelial sodium channels (ENaC).
Our lead program, SPX-101, is currently in a Phase 2 clinical trial, entitled "Hydration for Optimal Pulmonary Effectiveness" (HOPE-1), evaluating the efficacy of our approach in individuals living with CF. Spyryx Biosciences is committed to advancing understanding of airway hydration and respiratory biology through rigorous scientific research and development.
We are a team of dedicated scientists and clinicians driven by a passion for improving the lives of patients suffering from respiratory illnesses.
We are harnessing the power of our proprietary TEMPO platform to master the epigenome and unlock new treatments for complex diseases. Unlike gene editing, our ‘genetic tuning’ technology allows us to precisely control gene expression – activating, silencing, and fine-tuning – without altering the DNA sequence itself.
Tune Therapeutics is dedicated to expanding the reach of genetic medicine, moving beyond rare conditions to address common, chronic, and age-related diseases, ultimately transforming human healthspan.
Founded on cutting-edge advances in gene regulation, we are committed to bringing innovative therapies to patients worldwide.
We specialize in developing innovative solutions utilizing organoids, precision medicine, and artificial intelligence to revolutionize the way cancer is treated. Our core focus is on creating robust and reliable models for predicting drug efficacy and patient response, significantly reducing the time and cost associated with traditional research methods.
Xilis is dedicated to advancing oncology and cancer research by providing cutting-edge tools for tissue engineering, microfluidics, and screening. We are committed to transforming the landscape of drug development and ultimately improving patient outcomes through personalized therapies.
Founded in 2019, Xilis currently employs a team of 15 experts and is rapidly expanding its capabilities in ex vivo technology and machine learning.
We support researchers worldwide with a wide range of services, including whole genome sequencing (WGS), RNA-seq, and more, utilizing cutting-edge platforms like PacBio Revio and Illumina NovaSeq X Plus.
JS Link distinguishes itself through a long-standing commitment to advanced technology, a proven track record of thousands of successful projects, and competitive pricing. We’ve served over 600 researchers across 50 countries, consistently delivering reliable and insightful genomic data.
Our global reach extends to Seoul, South Korea, and the Netherlands, ensuring we can meet the diverse needs of our clients.
We specialize in partnering with pharmaceutical, biotech, and medical device companies to design, implement, and validate mission-critical systems, ensuring they meet the strictest standards of quality, compliance, and operational performance. Our experienced teams deliver comprehensive solutions, from automation and controls integration to robotics and cGMP cleanroom support.
Since 1997, Mangan Biopharm has built a strong reputation for reliability and expertise, helping clients accelerate time-to-market, mitigate risk, and confidently operate within complex regulatory environments. We offer a full suite of services including auditing, data integrity solutions, and process validation, supporting the entire lifecycle of facilities, utilities, equipment, and computerized systems.
Company Name | Location | Category | Employees | Website |
|---|---|---|---|---|
Irvine, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 50-100 | http://www.gabeinc.com | |
Irvine, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 50-100 | https://irvineclinical.com/ | |
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 50-100 | https://www.avioq.com | |
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 50-100 | http://www.genome.duke.edu | |
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 50-100 | https://grantengine.com | |
Research Triangle Park, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 50-100 | http://ycellbiousa.com | |
Irvine, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 200-500 | http://www.zymoresearch.com | |
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 200-500 | https://humacyte.com | |
Raleigh, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 200-500 | https://www.wakeresearch.com | |
Las Vegas, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 200-500 | https://eliteclinicalnetwork.com/ | |
Irvine, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 200-500 | https://ispe.org/greater-los-angeles-chapter | |
Irvine, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 200-500 | https://www.molbreeding.com | |
Columbia, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 200-500 | http://www.ameritox.com | |
Research Triangle Park, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 200-500 | https://www.womeninbio.org/page/rtp | |
New Jersey, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 200-500 | https://www.woda-alliance.com/ | |
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | http://www.ghiaa.org | |
Irvine, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 10-20 | http://nonagen.com | |
El Cajon, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | http://www.novabiotech.com | |
Irvine, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | http://www.aracaribio.com | |
Irvine, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | http://www.genizer.com | |
Jersey City, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | http://www.BioMAS.solutions | |
Fort Wayne, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | http://www.gtresearch.io | |
Lincoln, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | https://www.kennebecanalytical.com/ | |
St. Petersburg, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | http://www.clarosci.com | |
DURHAM, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | http://cscientist.com | |
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 20-30 | http://www.AltisBiosystems.com | |
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 10-20 | http://biomilq.com | |
Irvine, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 10-20 | https://btgenomics.com | |
Irvine, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | http://www.augnitionlabs.com | |
Research Triangle Park, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 30-50 | https://www.avalo.ai/ | |
Orlando, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 30-50 | http://www.hesperosinc.com/ | |
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 20-30 | https://www.vitakey.com | |
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 10-20 | http://boragenbio.com/ | |
Plano, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 10-20 | http://www.macrocyclics.com | |
IRVINE, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 10-20 | http://www.antigendiscovery.com/ | |
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 10-20 | http://www.spyryxbio.com | |
Seattle, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 50-100 | https://www.tunetx.com | |
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 50-100 | https://www.xilis.com | |
Orlando, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 50-100 | https://www.jslinkseqlab.com/ | |
Long Beach, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 200-500 | https://www.manganbio.com | |
Los Angeles, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 1 | https://www.abtriva.com/product/human-cyclin-d1-monoclonal-antibody-ada-17284a/ | |
Redwood City, United States (US) | Health and Medical +2 Health and Medical, Information Technology, Science and Engineering | 150-200 | http://www.kriyatx.com | |
Los Angeles, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 20-30 | https://bionautlabs.com/ | |
San Diego, United States (US) | Environment +1 Environment, Science and Engineering | 20-30 | https://www.algenesismaterials.com/ | |
Goleta, United States (US) | Agriculture and Livestock +1 Agriculture and Livestock, Science and Engineering | 200-500 | https://www.apeel.com/ | |
Cambridge, United States (US) | Agriculture and Livestock +1 Agriculture and Livestock, Science and Engineering | 50-100 | https://www.invaio.com/ | |
Washington, United States (US) | Food and Beverages +4 Food and Beverages, Information Technology, Health and Medical, Science and Engineering, Agriculture and Livestock | 10-20 | https://www.ryplabs.com/ | |
San Diego, United States (US) | Manufacturing and Industry +2 Manufacturing and Industry, Health and Medical, Science and Engineering | 500-1000 | https://abzena.com/ | |
Cambridge, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 50-100 | https://axolbio.com/ | |
Omaha, United States (US) | Science and Engineering Science and Engineering | 10-20 | https://www.bluestembiosciences.com/ |
200/633 results
Frequently asked questions
Updated 23 October 2026
What is Enterprise League?
Enterprise League is a free business directory that helps buyers find the right company by sector and country. Every company has a profile showing what it does, what it offers and how to get in touch.
Is it free to list my company?
Yes, and it stays free: no card, no paid tier. Your profile appears in search results and category pages, can show up to 20 products and services, and lets buyers message you or ask for a quote.
How does verification work, and what does it cost?
Verifying your company is free. Confirm a code we email to an address at your company’s website, or send a company registration document for our team to check, and the verified badge appears on your profile. To show the badge in the directory and search results as well, take out a subscription: the first 14 days are free, and the price is on our pricing page.
Where does the company information come from?
Most profiles are built from public sources, such as official company registers. Claim your company’s profile to correct its details and add your own.
How do I claim or correct my company’s profile?
Open your company’s profile and choose Claim Profile. If you use an email address at your company’s website, a 6-digit code makes the profile yours at once; otherwise our team reviews your request, usually within a few days. Spotted a mistake on a company that isn’t yours? Tell us through our contact page.